ZUSDURI™ Clinical Review Published in Reviews in Urology™ Highlights Durable Efficacy and Manageable Safety Profile in Recurrent Low-Grade, Intermediate-Risk Non–Muscle ...

Detailed price information for Urogen Pharma Ltd (URGN-Q) from The Globe and Mail including charting and trades.
The Malaysian Reserve

FDA-Cleared Lotus Catheter Accelerates Global Expansion, Backed by Peer-Reviewed Zero-UTI Study and 500,000+ Uses

Non-balloon catheter observed zero UTIs in a 50-patient study at the University of South Florida; >500,000 uses worldwide; company selectively ...

Struggling with urinary problems? What men should know about benign prostate hyperplasia

Benign Prostatic Hyperplasia (BPH) commonly affects men over 50, causing urinary issues due to an enlarged prostate. Age, ...

6 Medical Conditions That Mimic Prostate Cancer

Several medical conditions can mimic prostate cancer, causing many of the same symptoms, including painful ejaculation and blood in the urine. Some of these conditions can also cause elevated prostate ...

EG 427’s HSV gene therapy reduces urinary incontinence in Phase Ib/IIa trial

French biotech EG 427 has had success with its urinary incontinence DNA therapy, EG110A, showing a more than 80% reduction in ...

EG 427 Announces Compelling Initial Topline Clinical Results with EG110A DNA Medicine in Neurogenic Bladder Patients

Over 88% reduction in urinary incontinence episodes achieved in low dose cohort at 12 weeksGood tolerability with no systemic side effectsFirst DNA medicine to selectively target, at the local level, ...

25% of men will have an enlarged prostate by 50: What can be done now to prevent it

With growing age, many experience Benign Prostatic Hyperplasia (BPH) also known as an enlarged prostate. Research indicates ...